Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:PFE

Pfizer Inc (PFE)

26.19
+0.59 (2.30%)
as of Jun 11, 2026, 8:09:11 pm Market Open.
322 watching
0
TOP PICK
A defense stock. Ability to produce new drugs. Great patent protection. Great product line.
TOP PICK
Likes. Best product line and a good pipeline. AT a good price.
BUY
Cheap. Great pipeline. Low risk.
BUY
Should do well even in a recession. Good price.
TOP PICK
Prefers this and American Home over Lilly. Good product line.
TOP PICK
Aging population. Nine new drugs coming out in the next 3 years. Great pipeline. 40% growth.
PAST TOP PICK
(Was a top pick on Apr 12/01 even) Still a big fan. Good sector to be in. Strong pipeline. Reports are good. Good price.
BUY
Have a tremendous pipeline for new drugs.
BUY
Good short/long term growth potential. Great pipeline.
DON'T BUY
Suspicious of large cap drug companies. High risk industry.
BUY ON WEAKNESS
A little high now. Buy below $40.
TOP PICK
(Was a top pick on Jan 8/01 up 2%) Prefers over Merck. Less patent expiries. In a good position with good pipeline.
BUY
Likes both Pfizer and Merck in pharmaceuticals.
DON'T BUY
Caution. At its FMV.
TOP PICK
Least amount of patent expiry. Have some good new product launches. Good pipeline.
Showing 766 to 780 of 801 entries